P.C. Rensen
Division of Biopharmaceutics
Leiden-Amsterdam Center for Drug Research
University of Leiden
Sylvius Laboratories
Netherlands
Name/email consistency: high
- Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Rensen, P.C., de Vrueh, R.L., Kuiper, J., Bijsterbosch, M.K., Biessen, E.A., van Berkel, T.J. Adv. Drug Deliv. Rev. (2001)
- Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo. Rensen, P.C., Sliedregt, L.A., Ferns, M., Kieviet, E., van Rossenberg, S.M., van Leeuwen, S.H., van Berkel, T.J., Biessen, E.A. J. Biol. Chem. (2001)
- Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis. Rensen, P.C., Jong, M.C., van Vark, L.C., van der Boom, H., Hendriks, W.L., van Berkel, T.J., Biessen, E.A., Havekes, L.M. J. Biol. Chem. (2000)
- Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo. Rensen, P.C., Oosten, M., Bilt, E., Eck, M., Kuiper, J., Berkel, T.J. J. Clin. Invest. (1997)
- Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. Rensen, P.C., Schiffelers, R.M., Versluis, A.J., Bijsterbosch, M.K., Van Kuijk-Meuwissen, M.E., Van Berkel, T.J. Mol. Pharmacol. (1997)
- Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations. Rensen, P.C., de Vrueh, R.L., van Berkel, T.J. Clin. Pharmacokinet (1996)
